Altogether, our data agree with the recent proposition to consider FSHD as a satellite cell-opathy [99] and might explain why repression of PAX7-target gene signature is a superior FSHD marker than increase of DUX4 signature [71, 72]. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.